Distinct factors correlating with adverse cardiac events after major vascular surgery

VASA ◽  
2005 ◽  
Vol 34 (1) ◽  
pp. 46-49 ◽  
Author(s):  
Wunderlich ◽  
Gossrau ◽  
Wunderlich ◽  
Altmann

Introduction: Cardiovascular complications remain the principal cause of both morbidity and mortality after major vascular surgery. The well-known coincidence between vascular disease and coronary artery disease provided the rationale for a detailed analysis of major perioperative cardiovascular complications in their relation to preoperative and intraoperative parameter. Methods and Patients: 90 patients scheduled to undergo either femoral-popliteal bypass (n = 74) or repair of an infrarenal aortic aneurysm (n = 16) were prospectively included in the study. All patients had no signs of unstable cardiac disease and required no cardiac testing. Both preoperative and intraoperative parameter were correlated to adverse cardiac events (cardiac death and myocardial infarction -MI). Results: Univariate analysis identified the following parameter to be significantly related to cardiac complications: prior MI and intraoperative hypertension (systolic blood pressure above 200 mmHg). In contrast perioperative betablocker therapy was revealed to be protective. In multivariate analysis the history of MI and intraoperative hypertension correlated with poor cardiac outcome. Conclusions: Our results underline the importance of the individual history in predicting perioperative risk and corroborate the beneficial effects of long-standing beta-blocker therapy. Additionally the significance of stable intraoperative hemodynamic parameter is demonstrated.

2018 ◽  
Vol 28 (1) ◽  
pp. 63-69
Author(s):  
Mladjan Golubovic ◽  
Velimir Peric ◽  
Dragana Stanojevic ◽  
Milan Lazarevic ◽  
Nenad  Jovanovic ◽  
...  

Objective: The aim of our study was to find the best model with sufficient power to improve the risk stratification in major vascular surgery patients during the first 30 days after this procedure. The discriminatory power of 4 biomarkers (troponin I [TnI], N-terminal prohormone of brain natriuretic peptide [NT-proBNP], creatine kinase-MB isoenzyme [CK-MB], high-sensitivity C-reactive protein [hs-CRP]) was tested as well as 2 risk assessment models and 13 different combinations of them. Subjects and Methods: The study included 122 patients (77% men, 23% women) with an average age of 67.03 ± 4.5 years. An aortobifemoral bypass was performed in 6.56% of the patients, a femoropopliteal bypass in 18.85%, and 49.18% received open surgical reconstruction of the carotid arteries. A total of 25.41% of the patients were given an aortobi-iliac bypass. Results: During the first 30 days, 13 patients (10.7%) had 17 cardiac complications. The most common complication was the new onset of atrial fibrillation (35.3%). During the first 10 days, 10 patients had 1 complication and 2 patients had 2 cardiac events, while 1 patient had 3 complications. By comparing combinations of scores and markers, it was shown that revised cardiac risk index (RCRI) + Vascular Portsmouth Physiological and Operative Severity Score (V-POSSUM) + hsTnI and RCRI + V-POSSUM + hsTnI + NT-proBNP with 100% sensitivity, > 80% specificity had the best discriminatory ability (AUC 0.924 and 0.933, respectively; p < 0.001 for both models) for cardiac complications during the 30 days after surgery. Conclusion: Combinations of traditional preoperative risk factors and scores can enhance the assessment of major adverse cardiac events (MACE) in patients preparing for large vascular surgery. Using only one risk score in these patients seems to be underperforming in preoperative risk assessment.


2011 ◽  
Vol 45 (11) ◽  
pp. 1451-1451 ◽  
Author(s):  
Sammy Zakaria ◽  
Kit Yu Lu ◽  
Veronique Nussenblatt ◽  
Ilene Browner

Objective: To report a novel case of atrial flutter associated with carboplatin administration and review chemotherapy-related cardiac toxicities, focusing on platinum-containing compounds. Case Report: A 69-year-old man with extensive small cell lung cancer and asymptomatic cardiovascular and cerebrovascular disease was inconsistently adherent to his medication regimen. While undergoing carboplatin infusion, he developed atrial flutter. He had no other immediate arrhythmogenic causes of atrial flutter and the arrhythmia spontaneously reverted to sinus rhythm after 24 hours. His condition remained stable until he died 8 days later. The cause of death was unknown and the family declined postmortem examination. Discussion: Although this patient's cardiac history and nonadherence to his medications may have increased his susceptibility to develop atrial arrhythmias, the Naranjo probability scale reveals a possible relationship between atrial flutter and Infusion of carboplatin. A literature search revealed other adverse cardiac events due to platinum compounds; however, to our knowledge, this case is the first to describe an association with atrial flutter. A definitive causal link cannot be determined, but this may have been the result of a direct arrhythmogenic effect of treatment or to a novel hypersensitivity reaction. Given the potential deleterious impact of drug-induced arrhythmias, we have reported this case to the Food and Drug Administration as a new adverse effect of carboplatin. Conclusions: Providers should consider cardiac monitoring during carboplatin infusion in patients with known cardiac disease or at high risk of cardiac complications.


PLoS ONE ◽  
2015 ◽  
Vol 10 (4) ◽  
pp. e0123093 ◽  
Author(s):  
Claudia Schrimpf ◽  
Hans-Joerg Gillmann ◽  
Bianca Sahlmann ◽  
Antje Meinders ◽  
Jan Larmann ◽  
...  

2006 ◽  
Vol 18 (4) ◽  
pp. 280-285 ◽  
Author(s):  
Maria Barbagallo ◽  
Andrea Casati ◽  
Elisabetta Spadini ◽  
Gianluca Bertolizio ◽  
Lucy Kepgang ◽  
...  

1997 ◽  
Vol 26 (4) ◽  
pp. 570-578 ◽  
Author(s):  
Giora Landesberg ◽  
Sharon Einav ◽  
Rose Christopherson ◽  
Charles Beattie ◽  
Yacov Berlatzky ◽  
...  

JAMA ◽  
2001 ◽  
Vol 285 (14) ◽  
pp. 1865 ◽  
Author(s):  
Eric Boersma ◽  
Don Poldermans ◽  
Jeroen J. Bax ◽  
Ewout W. Steyerberg ◽  
Ian R. Thomson ◽  
...  

2013 ◽  
Vol 67 (10) ◽  
pp. e2.10-e2
Author(s):  
Thuvaraha Vanniyasingam ◽  
Lehana Thabane ◽  
Reitze Rodseth ◽  
Giovana A. Lurati Buse ◽  
Daniel Bolliger ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document